Gilbert SC - Search Results

1

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil.

Clemens SAC, Folegatti PM, Emary KRW, Weckx LY, Ratcliff J, Bibi S, De Almeida Mendes AV, Milan EP, Pittella A, Schwarzbold AV, Sprinz E, Aley PK, Bonsall D, Fraser C, Fuskova M, Gilbert SC, Jenkin D, Kelly S, Kerridge S, Lambe T, Marchevsky NG, Mujadidi YF, Plested E, Ramasamy MN, Simmonds P, Golubchik T, Voysey M, Pollard AJ; AMPHEUS Project; Oxford COVID Vaccine Trial Team. Clemens SAC, et al. Among authors: gilbert sc. Nat Commun. 2021 Oct 6;12(1):5861. doi: 10.1038/s41467-021-25982-w. Nat Commun. 2021. PMID: 34615860 Free PMC article. Clinical Trial.

2

Genetic analysis of host-parasite coevolution in human malaria.

Hill AV, Jepson A, Plebanski M, Gilbert SC. Hill AV, et al. Among authors: gilbert sc. Philos Trans R Soc Lond B Biol Sci. 1997 Sep 29;352(1359):1317-25. doi: 10.1098/rstb.1997.0116. Philos Trans R Soc Lond B Biol Sci. 1997. PMID: 9355123 Free PMC article. Review.

3

A protein particle vaccine containing multiple malaria epitopes.

Gilbert SC, Plebanski M, Harris SJ, Allsopp CE, Thomas R, Layton GT, Hill AV. Gilbert SC, et al. Nat Biotechnol. 1997 Nov;15(12):1280-4. doi: 10.1038/nbt1197-1280. Nat Biotechnol. 1997. PMID: 9359112

4

DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice.

Hanke T, Schneider J, Gilbert SC, Hill AV, McMichael A. Hanke T, et al. Among authors: gilbert sc. Vaccine. 1998 Feb;16(4):426-35. doi: 10.1016/s0264-410x(97)00296-x. Vaccine. 1998. PMID: 9607066

5

Altered peptide ligands narrow the repertoire of cellular immune responses by interfering with T-cell priming.

Plebanski M, Lee EA, Hannan CM, Flanagan KL, Gilbert SC, Gravenor MB, Hill AV. Plebanski M, et al. Among authors: gilbert sc. Nat Med. 1999 May;5(5):565-71. doi: 10.1038/8444. Nat Med. 1999. PMID: 10229235

6

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis.

McShane H, Brookes R, Gilbert SC, Hill AV. McShane H, et al. Among authors: gilbert sc. Infect Immun. 2001 Feb;69(2):681-6. doi: 10.1128/IAI.69.2.681-686.2001. Infect Immun. 2001. PMID: 11159955 Free PMC article.

7

Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes.

Gilbert SC, Schneider J, Hannan CM, Hu JT, Plebanski M, Sinden R, Hill AV. Gilbert SC, et al. Vaccine. 2002 Jan 15;20(7-8):1039-45. doi: 10.1016/s0264-410x(01)00450-9. Vaccine. 2002. PMID: 11803063

8

Protein particle vaccines against malaria.

Gilbert SC, Hill AV. Gilbert SC, et al. Parasitol Today. 1997 Aug;13(8):302-6. doi: 10.1016/s0169-4758(97)01091-0. Parasitol Today. 1997. PMID: 15275056

9

Dendritic cells infected by recombinant modified vaccinia virus Ankara retain immunogenicity in vivo despite in vitro dysfunction.

Behboudi S, Moore A, Gilbert SC, Nicoll CL, Hill AV. Behboudi S, et al. Among authors: gilbert sc. Vaccine. 2004 Oct 22;22(31-32):4326-31. doi: 10.1016/j.vaccine.2004.04.029. Vaccine. 2004. PMID: 15474725

10

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.

McShane H, Pathan AA, Sander CR, Keating SM, Gilbert SC, Huygen K, Fletcher HA, Hill AV. McShane H, et al. Among authors: gilbert sc. Nat Med. 2004 Nov;10(11):1240-4. doi: 10.1038/nm1128. Epub 2004 Oct 24. Nat Med. 2004. PMID: 15502839 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

293 results

Search Page